Marilee Moy - 24 Feb 2022 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
Chief People Officer
Signature
/s/ Marilee Moy, by Brian McKelligon, as Attorney-in-Fact
Issuer symbol
AKYA
Transactions as of
24 Feb 2022
Net transactions value
$0
Form type
4
Filing time
28 Feb 2022, 17:23:42 UTC
Previous filing
24 Jan 2022
Next filing
27 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AKYA Employee Stock Option (Right to Buy) Award $0 +120,000 $0.000000 120,000 24 Feb 2022 Common Stock 120,000 $10.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the reporting person's continuous employment, the option shall vest as follows: (1/4) of such shares on January 10, 2023, with the remaining shares vesting in 36 equal monthly installments beginning on February 10, 2023, until fully vested.